Search Results - "Alkhattabi, M"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
  2. 2
  3. 3

    P666 Safety of combination biologic and immunosuppressive therapy post-orthotopic liver transplantation in patients with inflammatory bowel disease: a systematic review by Al Draiweesh, S, Ma, C, Alkhattabi, M, Nguyen, T, Brahmania, M, Jairath, V

    Published in Journal of Crohn's and colitis (25-01-2019)
    “…Abstract Background inflammatory bowel disease (IBD) patients post orthotopic liver transplantation (OLT) often have ongoing mucosal inflammation necessitating…”
    Get full text
    Journal Article
  4. 4

    Perceived Knowledge, Guidelines Concordance, and Practices of Physicians for Management of Recurrent Urinary Tract Infections in Women by Aldabeeb, Dana, Alenzi, Ebtihag O, Alhaizan, Maysoon, Alkhattabi, Mashael, Barry, Mazin, Alalshaikh, Nouf Khalid, Temsah, Mohamad-Hani, Al-Tawfiq, Jaffar A, Alshaikh, Ghadeer

    Published in International journal of general medicine (31-08-2024)
    “…Recurrent urinary tract infections (rUTIs) are common complaints that burden the healthcare system. Reporting perceived knowledge and guidelines in concordance…”
    Get full text
    Journal Article
  5. 5

    P473 Contrasting the use of 5-ASA in patients with Ulcerative Colitis and Crohn's Disease: A cross-sectional analysis at a tertiary care IBD clinic by Alkhattabi, M, Jairath, V, Chande, N, Walton-Mennill, P, Gregor, J

    Published in Journal of Crohn's and colitis (16-01-2018)
    “…Abstract Background 5-ASA is a mainstay of initial induction and maintenance therapy in patients with ulcerative colitis (UC). Although often used in patients…”
    Get full text
    Journal Article
  6. 6

    A225 THE UTILITY OF SEPARATE DISTAL AND MID-ESOPHAGEAL BIOPSIES IN THE DIAGNOSIS OF EOSINOPHILIC ESOPHAGITIS (EOE) by Alkhattabi, M, Kubica, M, Driman, D, Gregor, J C

    “…Abstract Background EoE is an increasingly recognized cause of upper gastrointestinal symptomatology particularly dysphagia. The gold standard for diagnosis is…”
    Get full text
    Journal Article
  7. 7

    A126 SAFETY OF COMBINATION BIOLOGIC AND IMMUNOSUPPRESSIVE THERAPY POST-ORTHOTOPIC LIVER TRANSPLANTATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW by Al Draiweesh, S, Ma, C, Alkhattabi, M, Nguyen, T, Brahmania, M, Jairath, V

    “…Abstract Background Inflammatory Bowel Disease (IBD) patients post orthotopic liver transplantation (OLT) often have ongoing mucosal inflammation necessitating…”
    Get full text
    Journal Article
  8. 8

    DOP39 Safety of combination biologic and anti-rejection therapy post-liver transplantation in patients with inflammatory bowel disease: London Ontario experience by Al Draiweesh, S, Ma, C, Alkhattabi, M, Chande, N, Feagan, B G, Gregor, J C, Khanna, R, Marotta, P, Sandhu, A, Qumosani, K, Teriaky, A, Brahmania, M, Jairath, V

    Published in Journal of Crohn's and colitis (25-01-2019)
    “…Abstract Background Despite anti-rejection immunosuppressive therapies post-liver transplantation (LT), patients with concurrent inflammatory bowel disease…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Ovarian mucinous cystadenoma in a female with Turner syndrome by Sait, Khalid H, Alkhattabi, Maysoon A, Alkushi, Abdulmohsen O, Alqahtani, Mohammed H

    Published in Saudi medical journal (01-09-2004)
    “…The development of an epithelial tumor, especially mucinous type, in a female with a streak gonad is rare and not fully understood. We report a case of a…”
    Get more information
    Journal Article